Skip to main content
. Author manuscript; available in PMC: 2010 Jun 14.
Published in final edited form as: Circ Heart Fail. 2010 Jan 8;3(2):212–219. doi: 10.1161/CIRCHEARTFAILURE.109.879684

Table 1.

Participant Characteristics

Healthy Control HF P
Demographics
 Age, y 43±3 51±5 0.21
 Gender, male/female 7/4 7/4 1.00
 Height, m 1.76±0.02 1.73±0.02 0.35
 Weight, kg 78.3±3.3 87.4±5.6 0.18
 BMI, kg/m2 25.2±1.1 29.1±1.8 0.10
 BSA, m2 2.0±0.1 2.0±0.1 0.33
 VO2peak, mL · kg−1 · min−1 36.0±3.0 17.5±1.4 <0.001
 LVEF, % 32.1±2.8
 CHF etiology (ischemic/idiopathic) 4/7
 NYHA class
  I 4
  II 7
Medications
 ACE inhibitors 6 (55)
 Angiotensin II receptor blockers 4 (36)
 Aspirin 7 (64)
 β-blockers 10 (91)
 Digitalis 4 (36)
 Diuretics 7 (64)

Data are presented as mean±SEM or as n (%). ACE indicates angiotensin-converting enzyme; BMI, body mass index; BSA, body surface area; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.